Revivocell is delighted to have been awarded Future Innovation Fund from the Liverpool City Region for the development of a novel screening tool for COVID-19 virus.
With the current COVID-19 pandemic there remains great uncertainty about number of future infections and possible deaths. There is a need for more accurate and cost effective detection tools that can be widely used without highly specialised training and expensive equipment. The current established detection tools are expensive and require dedicated equipment, trained personnel and numerous reagents which are running low.
Revivocell will be collaborating with Daresbury Proteins to develop the new COVID-19 testing platform, which is rapid, easy to use, lower cost and highly accurate.